Portfolio concentration
As of March 31, 2026 · N-PORT
Holdings
51
Top-10 weight
54.13%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
24
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
1249.3
Holdings
As of March 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | JOHNSON&JOHNSON | — | 8,893 | $2.17M | 7.45% |
| 2 | BRISTOL-MYERS SQUIBB CO | — | 35,422 | $2.15M | 7.36% |
| 3 | MERCK & CO | — | 17,843 | $2.15M | 7.36% |
| 4 | ABBVIE INC | — | 9,520 | $2.07M | 7.10% |
| 5 | LILLY ELI and CO | — | 2,100 | $1.93M | 6.62% |
| 6 | PFIZER INC | — | 39,951 | $1.12M | 3.85% |
| 7 | REGENERON PHARMACEUTICALS INC | — | 1,413 | $1.09M | 3.74% |
| 8 | BIOGEN INC | — | 5,759 | $1.06M | 3.62% |
| 9 | GILEAD SCIENCES INC | — | 7,416 | $1.03M | 3.54% |
| 10 | CARDINAL HEALTH INC | — | 4,819 | $1.02M | 3.49% |
| 11 | AMGEN INC | — | 2,846 | $1.00M | 3.43% |
| 12 | VIATRIS INC | — | 73,989 | $999.59K | 3.43% |
| 13 | ZOETIS INC CL A | — | 8,426 | $996.04K | 3.41% |
| 14 | VERTEX PHARMACEUTICALS INC | — | 2,223 | $992.66K | 3.40% |
| 15 | UNITED THERAPEUTICS CORP DEL | — | 1,630 | $966.56K | 3.31% |
| 16 | INCYTE CORP | — | 6,843 | $644.06K | 2.21% |
| 17 | JAZZ PHARMA PLC | — | 3,347 | $632.75K | 2.17% |
| 18 | ILLUMINA INC | — | 3,657 | $450.76K | 1.55% |
| 19 | EXELIXIS INC | — | 10,279 | $440.87K | 1.51% |
| 20 | MEDPACE HOLDINGS INC | — | 865 | $415.36K | 1.42% |
| 21 | PTC THERAPEUTICS INC | — | 5,449 | $371.24K | 1.27% |
| 22 | CHARLES RIVER LABS INTL INC | — | 2,127 | $366.91K | 1.26% |
| 23 | BIOMARIN PHARMACEUTICAL INC | — | 6,318 | $356.90K | 1.22% |
| 24 | NEUROCRINE BIOSCIENCES INC | — | 2,630 | $346.48K | 1.19% |
| 25 | HALOZYME THERAPEUTICS INC | — | 5,005 | $323.47K | 1.11% |
| 26 | ALKERMES PLC | — | 8,380 | $296.32K | 1.02% |
| 27 | ELANCO ANIMAL HEALTH INC | — | 10,925 | $261.44K | 0.90% |
| 28 | SPYRE THERAPEUTICS INC | — | 3,533 | $178.20K | 0.61% |
| 29 | PROTAGONIST THERAPEUTICS INC | — | 1,650 | $173.91K | 0.60% |
| 30 | TG THERAPEUTICS INC | — | 5,049 | $167.73K | 0.57% |
| 31 | ARROWHEAD PHARMACEUTICALS INC | — | 2,611 | $163.71K | 0.56% |
| 32 | CATALYST PHARMACEUTICALS INC | — | 6,583 | $163.00K | 0.56% |
| 33 | AMNEAL PHARM INC | — | 12,984 | $161.39K | 0.55% |
| 34 | ARCUS BIOSCIENCES INC | — | 7,459 | $161.11K | 0.55% |
| 35 | TWIST BIOSCIENCE CORP | — | 3,238 | $153.87K | 0.53% |
| 36 | LIGAND PHARMACEUTICALS | — | 766 | $152.93K | 0.52% |
| 37 | MIRUM PHARMACEUTICALS INC | — | 1,646 | $152.06K | 0.52% |
| 38 | TRAVERE THERAPEUTICS INC | — | 5,100 | $151.52K | 0.52% |
| 39 | ALNYLAM PHARMACEUTICALS INC | — | 456 | $150.88K | 0.52% |
| 40 | GUARDANT HEALTH INC | — | 1,618 | $149.45K | 0.51% |
| 41 | ROIVANT SCIENCES LTD | — | 5,250 | $145.42K | 0.50% |
| 42 | MODERNA INC | — | 2,836 | $144.07K | 0.49% |
| 43 | SUPERNUS PHARMACEUTICALS INC | — | 2,776 | $143.49K | 0.49% |
| 44 | KRYSTAL BIOTECH INC | — | 551 | $142.33K | 0.49% |
| 45 | TARSUS PHARMACEUTICALS INC | — | 2,012 | $141.14K | 0.48% |
| 46 | IONIS PHARMACEUTICALS INC | — | 1,872 | $140.57K | 0.48% |
| 47 | 10X GENOMICS INC | — | 6,591 | $139.93K | 0.48% |
| 48 | KYMERA THERAPEUTICS INC | — | 1,663 | $138.51K | 0.47% |
| 49 | ACADIA PHARMACEUTICALS INC | — | 6,186 | $137.70K | 0.47% |
| 50 | ARCUTIS BIOTHERAPEUTICS INC | — | 5,633 | $132.71K | 0.45% |
1 / 2
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.